Our findings along with previous results reinforce the idea that FoxO1 connects overnutrition and insulin resistance to abnormal macrophage activation, contributing to chronic low-grade inflammation and NASH in obesity. Here, FOXO1 is linked to metabolic dysfunction-associated steatohepatitis.